Molecular identification and structural detection of anti-cancer compound from marine Streptomyces akiyoshiensis GRG 6 (KY457710) against MCF-7 breast cancer cells
Molecular identification and structural detection of anti-cancer compound from marine Streptomyces akiyoshiensis GRG 6 (KY457710) against MCF-7 breast cancer cells
复制标题
海洋秋吉链霉菌 GRG 6 (KY457710) 抗 MCF-7 乳腺癌细胞抗癌化合物的分子鉴定和结构检测
DOI:
10.1016/j.jksus.2020.10.008
复制
发表时间:
2020-12-01
影响因子:
3.8
通讯作者:
Li, Wen-Jun
中科院分区:
文献类型:
--
作者:
Rajivgandhi, Govindan Nadar;Ramachandran, Govindan;Li, Wen-Jun
The current study was concentrated to detection of anti-cancer compound from marine Streptomyces akiyoshiensis GRG 6 (KY457710) against MCF-7 breast cancer cells. The partial purification of TLC was moved three different active spots. Among the spots, the third spot of the extract was shown excellent anti-cancer properties against MCF-7 human breast cancer cells. The available anti-cancer compounds present in the partially purified extract was confirmed by GC-MS data interpretation. Three fractions of the compounds were purified by preparative HPLC and their respective spectrum was confirmed by analytical HPLC. Active anti-cancer fraction was separately purified by preparative HPLC and the cytotox-icity result was shown with 100 mg/mL concentration. The anti-cancer compound of pyrrolo [1,2-a] pyrazine-1,4-dione, hexahydro-3 was detected by LC-MS analysis after interpretation with GC-MS data. Further, the morphological damages and increased proliferation with more death cells of pyrrolo[1,2-a] pyrazine-1,4-dione, hexahydro-3 treated MCF-7 were observed by phase contrast and fluorescence microscope techniques. Finally, the nuclear condensation and increased necrotic cells of the pyrrolo[1, 2-a]pyrazine-1,4-dione, hexahydro-3 treated MCF-7 cells was clearly identified by fluorescence microscope techniques using Hoechst 33,342 stain. Therefore, our result was prove, the pyrrolo[1,2-a]pyra zine-1,4-dione, hexahydro-3 rich Streptomyces akiyoshiensis GRG 6 (KY457710) as a potential anticancer agent against MCF-7 breast cancer cells. (c) 2020 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).